Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.46 USD | +6.02% |
|
+18.70% | +28.17% |
Jul. 02 | Inozyme Pharma Says US FDA Granted Fast Track Designation to INZ-701 to Treat ABCC6 Deficiency | MT |
Jul. 02 | Inozyme Pharma Gets FDA Fast Track Designation for INZ-701 in ABCC6 Deficiency | DJ |
- Stock Market
- Equities
- INZY Stock
- News Inozyme Pharma, Inc.
- Trading Ideas